- Home
- PLRX vs VINP Comparison
PLRX vs VINP Comparison
Compare PLRX & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- VINP
- Stock Information
- Founded
- PLRX 2015
- VINP 2009
- Country
- PLRX United States
- VINP Brazil
- Employees
- PLRX N/A
- VINP N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- VINP Investment Managers
- Sector
- PLRX Health Care
- VINP Finance
- Exchange
- PLRX Nasdaq
- VINP Nasdaq
- Market Cap
- PLRX 84.7M
- VINP 593.2M
- IPO Year
- PLRX 2020
- VINP 2021
- Fundamental
- Price
- PLRX $1.16
- VINP $9.51
- Analyst Decision
- PLRX Hold
- VINP Strong Buy
- Analyst Count
- PLRX 10
- VINP 2
- Target Price
- PLRX $9.79
- VINP $13.25
- AVG Volume (30 Days)
- PLRX 1.4M
- VINP 47.4K
- Earning Date
- PLRX 08-06-2025
- VINP 08-06-2025
- Dividend Yield
- PLRX N/A
- VINP 6.75%
- EPS Growth
- PLRX N/A
- VINP N/A
- EPS
- PLRX N/A
- VINP 0.38
- Revenue
- PLRX N/A
- VINP $126,696,258.00
- Revenue This Year
- PLRX N/A
- VINP $70.28
- Revenue Next Year
- PLRX N/A
- VINP $14.37
- P/E Ratio
- PLRX N/A
- VINP $25.30
- Revenue Growth
- PLRX N/A
- VINP 57.51
- 52 Week Low
- PLRX $1.10
- VINP $8.66
- 52 Week High
- PLRX $16.10
- VINP $11.62
- Technical
- Relative Strength Index (RSI)
- PLRX 34.14
- VINP 47.61
- Support Level
- PLRX $1.23
- VINP $9.41
- Resistance Level
- PLRX $1.43
- VINP $9.70
- Average True Range (ATR)
- PLRX 0.11
- VINP 0.23
- MACD
- PLRX -0.02
- VINP 0.01
- Stochastic Oscillator
- PLRX 3.92
- VINP 43.48
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.